MoneyWorks4Me

Kilitch Drugs(India) - Quaterly Results

19 May 2025 Evaluate
The sales surged to Rs. 563.04 millions, up 43.87% for the March 2025 quarter as against Rs. 391.36 millions during the corresponding quarter previous year.Net Profit for the quarter ended March 2025 zoomed to 212.27% from Rs. 36.42 millions to Rs. 113.73  millions.The company reported a good operating profit of 162.30 millions compared to 61.13 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 563.04 391.36 43.87 1815.87 1315.99 37.99 1815.87 1315.99 37.99
Other Income 23.25 8.96 159.49 137.15 61.89 121.60 137.15 61.89 121.60
PBIDT 162.30 61.13 165.50 445.53 265.06 68.09 445.53 265.06 68.09
Interest 7.21 4.45 62.02 21.26 19.08 11.43 21.26 19.08 11.43
PBDT 155.09 56.68 173.62 424.27 245.98 72.48 424.27 245.98 72.48
Depreciation 5.11 4.10 24.63 17.37 12.44 39.63 17.37 12.44 39.63
PBT 149.98 52.58 185.24 406.90 233.54 74.23 406.90 233.54 74.23
TAX 36.25 16.16 124.32 95.33 57.79 64.96 95.33 57.79 64.96
Deferred Tax 0.66 3.01 -78.07 -3.17 -5.86 -45.90 -3.17 -5.86 -45.90
PAT 113.73 36.42 212.27 311.57 175.75 77.28 311.57 175.75 77.28
Equity 160.82 160.82 0.00 160.82 160.82 0.00 160.82 160.82 0.00
PBIDTM(%) 28.83 15.62 84.54 24.54 20.14 21.82 24.54 20.14 21.82
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..